The Threshold team is made up of experienced research scientists, entrepreneurs, and business professionals with successful track records in the biotech industry. Senior management and advisors are authorities in the field of oncology and have been instrumental in building numerous industry leading companies including Amgen, Genentech, Affymax, Camitro, Coulter Pharmaceuticals, Gilead, Maxygen, Protein Design Labs and Scripps.

• Harold E. Selick, Ph.D.
  Chief Executive Officer



• John G. Curd, M.D.
  President and Chief Medical Officer



• Joel Fernandes
  Senior Director, Finance and Controller



• Stewart M. Kroll
  Vice President, Biostatistics and Clinical Operations



• Mark D. Matteucci, Ph.D.
  Senior Vice President, Discovery Research